Document is current
Any future updates will be listed below
-
Authors
Zhang, Qingfu
Du, Aolin
Li, Zhichao
Gu, Hui
Huang, Wanqi
Li, Ying
Han, Su
Wang, Chuanhe
Sun, Zhijun
-
Funding
Funding for this research was provided by:
the Science and Technology Program of Liaoning Province (101500005)
- License Information
-
More Information
Article History
Received: 10 November 2025
Accepted: 4 March 2026
First Online: 14 March 2026
Declarations
:
: All animal experiments were performed according to the protocol approved by the Experimental Animal Ethics Committee of Shengjing Hospital Affiliated to China Medical University (2023PS1249K). The clinical studies were approved by the Medical Ethics Committee of Shengjing Hospital Affiliated to China Medical Universitys (2025PS1577K). Human material Peripheral blood samples were provided by 12 healthy individuals, 12 AMI patient. The diagnostic criteria for AMI patients were according to the ESC/AHA/ACC guidelines. The study participants were patients with AMI based on electrocardiographic diagonal evidence, chest pain, and diagnostic cardiac catheterization at Shengjing Hospital Affiliated to China Medical University. The exclusion criteria were: (1) diabetes, (2) infectious diseases, and (3) other contraindications including tumors and nephritic or hepatic diseases. This experiment was conducted in accordance with the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.
